180 related articles for article (PubMed ID: 19650787)
1. Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas.
Cho HY; Cho SW; Kim SW; Shin CS; Park KS; Kim SY
Clin Endocrinol (Oxf); 2010 May; 72(5):648-53. PubMed ID: 19650787
[TBL] [Abstract][Full Text] [Related]
2. Silent corticotroph adenomas: Emory University cohort and comparison with ACTH-negative nonfunctioning pituitary adenomas.
Ioachimescu AG; Eiland L; Chhabra VS; Mastrogianakis GM; Schniederjan MJ; Brat D; Pileggi AV; Oyesiku NM
Neurosurgery; 2012 Aug; 71(2):296-303; discussion 304. PubMed ID: 22517250
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive long-term retrospective analysis of silent corticotrophic adenomas vs hormone-negative adenomas.
Jahangiri A; Wagner JR; Pekmezci M; Hiniker A; Chang EF; Kunwar S; Blevins L; Aghi MK
Neurosurgery; 2013 Jul; 73(1):8-17; discussion 17-8. PubMed ID: 23685641
[TBL] [Abstract][Full Text] [Related]
4. A spectrum of behaviour in silent corticotroph pituitary adenomas.
Baldeweg SE; Pollock JR; Powell M; Ahlquist J
Br J Neurosurg; 2005 Feb; 19(1):38-42. PubMed ID: 16147581
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of silent corticotroph adenomas.
Alahmadi H; Lee D; Wilson JR; Hayhurst C; Mete O; Gentili F; Asa SL; Zadeh G
Acta Neurochir (Wien); 2012 Aug; 154(8):1493-8. PubMed ID: 22619024
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic correlations of silent corticotroph adenomas of the pituitary: report of four cases and literature review.
Sahli R; Christ ER; Seiler R; Kappeler A; Vajtai I
Pathol Res Pract; 2006; 202(6):457-64. PubMed ID: 16497445
[TBL] [Abstract][Full Text] [Related]
7. Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review.
Langlois F; Lim DST; Yedinak CG; Cetas I; McCartney S; Cetas J; Dogan A; Fleseriu M
Pituitary; 2018 Feb; 21(1):32-40. PubMed ID: 29032459
[TBL] [Abstract][Full Text] [Related]
8. Clinical Parameters to Distinguish Silent Corticotroph Adenomas from Other Nonfunctioning Pituitary Adenomas.
Kim D; Ku CR; Park SH; Moon JH; Kim EH; Kim SH; Lee EJ
World Neurosurg; 2018 Jul; 115():e464-e471. PubMed ID: 29678704
[TBL] [Abstract][Full Text] [Related]
9. GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence.
Arnold JR; Arnold DF; Marland A; Karavitaki N; Wass JA
Clin Endocrinol (Oxf); 2009 Mar; 70(3):435-8. PubMed ID: 19236640
[TBL] [Abstract][Full Text] [Related]
10. Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile.
Batista RL; Trarbach EB; Marques MD; Cescato VA; da Silva GO; Herkenhoff CGB; Cunha-Neto MB; Musolino NR
World Neurosurg; 2018 Dec; 120():e241-e246. PubMed ID: 30138730
[TBL] [Abstract][Full Text] [Related]
11. Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently.
Bradley KJ; Wass JA; Turner HE
Clin Endocrinol (Oxf); 2003 Jan; 58(1):59-64. PubMed ID: 12519413
[TBL] [Abstract][Full Text] [Related]
12. Proliferation index of nonfunctioning pituitary adenomas: correlations with clinical characteristics and long-term follow-up results.
Losa M; Franzin A; Mangili F; Terreni MR; Barzaghi R; Veglia F; Mortini P; Giovanelli M
Neurosurgery; 2000 Dec; 47(6):1313-8; discussion 1318-9. PubMed ID: 11126902
[TBL] [Abstract][Full Text] [Related]
13. [Natural history study of postoperative residual non-functioning pituitary adenomas].
Wu ZB; Chen Y; Lü QP; Wang CD; Su ZP; Wu JS; Zheng WM; Zhuge QC
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):597-600. PubMed ID: 20450781
[TBL] [Abstract][Full Text] [Related]
14. Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes.
Cooper O; Ben-Shlomo A; Bonert V; Bannykh S; Mirocha J; Melmed S
Horm Cancer; 2010 Apr; 1(2):80-92. PubMed ID: 20717480
[TBL] [Abstract][Full Text] [Related]
15. Gender-related differences in non-functioning pituitary adenomas.
Schaller B
Neuro Endocrinol Lett; 2003 Dec; 24(6):425-30. PubMed ID: 15073569
[TBL] [Abstract][Full Text] [Related]
16. Cystic versus non-cystic silent corticotrophic adenomas: clinical and histological analysis of 62 cases after microscopic transsphenoidal surgery-a retrospective, single-center study.
Sumislawski P; Huckhagel T; Krajewski KL; Aberle J; Saeger W; Flitsch J; Rotermund R
Sci Rep; 2023 Feb; 13(1):2468. PubMed ID: 36774403
[TBL] [Abstract][Full Text] [Related]
17. The natural history of surgically treated but radiotherapy-naïve nonfunctioning pituitary adenomas.
O'Sullivan EP; Woods C; Glynn N; Behan LA; Crowley R; O'Kelly P; Smith D; Thompson CJ; Agha A
Clin Endocrinol (Oxf); 2009 Nov; 71(5):709-14. PubMed ID: 19302582
[TBL] [Abstract][Full Text] [Related]
18. Silent corticotroph adenomas after stereotactic radiosurgery: a case-control study.
Xu Z; Ellis S; Lee CC; Starke RM; Schlesinger D; Lee Vance M; Lopes MB; Sheehan J
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):903-10. PubMed ID: 25216855
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes after Gamma Knife radiosurgery for patients with a nonfunctioning pituitary adenoma.
Gopalan R; Schlesinger D; Vance ML; Laws E; Sheehan J
Neurosurgery; 2011 Aug; 69(2):284-93. PubMed ID: 21792138
[TBL] [Abstract][Full Text] [Related]
20. Biochemical remission and recurrence rate of secreting pituitary adenomas after transsphenoidal adenomectomy: long-term endocrinologic follow-up results.
Santoro A; Minniti G; Ruggeri A; Esposito V; Jaffrain-Rea ML; Delfini R
Surg Neurol; 2007 Nov; 68(5):513-8; discussion 518. PubMed ID: 17961741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
